Cargando…

N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma

Background: N6-methyladenosine (m6A) RNA methylation is an important epigenetic modification affecting alternative splicing (AS) patterns of genes to regulate gene expression. AS drives protein diversity and its imbalance may be an important factor in tumorigenesis. However, the clinical significanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maimaiti, Aierpati, Tuersunniyazi, Abudireheman, Meng, Xianghong, Pei, Yinan, Ji, Wenyu, Feng, Zhaohai, Jiang, Lei, Wang, Zengliang, Kasimu, Maimaitijiang, Wang, Yongxin, Shi, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355308/ https://www.ncbi.nlm.nih.gov/pubmed/35937991 http://dx.doi.org/10.3389/fgene.2022.872186

Ejemplares similares

Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma
por: Maimaiti, Aierpati, et al.
Publicado: (2021)

N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma
por: Maimaiti, Aierpati, et al.
Publicado: (2023)

Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas
por: Maimaiti, Aierpati, et al.
Publicado: (2022)

Identification of VASH1 as a Potential Prognostic Biomarker of Lower-Grade Glioma by Quantitative Proteomics and Experimental Verification
por: Aili, Yirizhati, et al.
Publicado: (2022)

Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma
por: Qin, Hu, et al.
Publicado: (2023)

CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma
por: Mijiti, Maimaitili, et al.
Publicado: (2023)

Modulation of transcriptional activity in brain lower grade glioma by alternative splicing
por: Li, Jin, et al.
Publicado: (2018)

m6A regulator–mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in patients with intracranial aneurysms
por: Maimaiti, Aierpati, et al.
Publicado: (2022)

An immunogenic cell death-related regulators classification patterns and immune microenvironment infiltration characterization in intracranial aneurysm based on machine learning
por: Turhon, Mirzat, et al.
Publicado: (2022)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Tumor microenvironment and exosomes in brain metastasis: Molecular mechanisms and clinical application
por: Aili, Yirizhati, et al.
Publicado: (2022)

Development of a nomogram for prognostic prediction of lower‐grade glioma based on alternative splicing signatures
por: Wang, Yaning, et al.
Publicado: (2020)

The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma
por: Wang, Zengliang, et al.
Publicado: (2022)

Classification of glioma based on prognostic alternative splicing
por: Li, Yaomin, et al.
Publicado: (2019)

An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma
por: Tang, Guihua, et al.
Publicado: (2023)

Tumor microenvironment–associated modifications of alternative splicing
por: Brosseau, Jean-Philippe, et al.
Publicado: (2014)

A novel prognostic 7-methylguanosine signature reflects immune microenvironment and alternative splicing in glioma based on multi-omics analysis
por: Wang, Zihan, et al.
Publicado: (2022)

The Role of Exosomal miRNAs in Glioma: Biological Function and Clinical Application
por: Aili, Yirizhati, et al.
Publicado: (2021)

Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort
por: Liu, Wang-Rui, et al.
Publicado: (2020)

Splicing is an alternate oncogenic pathway activation mechanism in glioma
por: Siddaway, Robert, et al.
Publicado: (2022)

HGG-39. ALTERNATIVE SPLICING OF NEUROFIBROMIN 1 IS ASSOCIATED WITH ELEVATED MAPK ACTIVITY AND POOR PROGNOSIS IN HIGH-GRADE GLIOMA
por: Siddaway, Robert, et al.
Publicado: (2021)

Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Microenvironment Changes (in pH) Affect VEGF Alternative Splicing
por: Elias, Ana Paula, et al.
Publicado: (2008)

Computer Analysis of Glioma Transcriptome Profiling: Alternative Splicing Events
por: Babenko, Vladimir N., et al.
Publicado: (2017)

N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3′-end processing
por: Bartosovic, Marek, et al.
Publicado: (2017)

Peritumoral Microenvironment in High-Grade Gliomas: From FLAIRectomy to Microglia–Glioma Cross-Talk
por: Altieri, Roberto, et al.
Publicado: (2021)

Re-irradiation alternatives for recurrent high-grade glioma
por: Dong, Yuanli, et al.
Publicado: (2016)

PAICS is related to glioma grade and can promote glioma growth and migration
por: Du, Baoshun, et al.
Publicado: (2021)

N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer
por: Lai, Shihui, et al.
Publicado: (2022)

N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non–Small Cell Lung Cancer Prognosis
por: Zhao, Zhenyu, et al.
Publicado: (2021)

Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma
por: Ye, Zai-Sheng, et al.
Publicado: (2021)

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma
por: Chen, Bo, et al.
Publicado: (2021)

Correlation of Clinicopathological Factors with Brain Tumor-Related Epilepsy in Glioma
por: Wang, Zengliang, et al.
Publicado: (2022)

GFAP Alternative Splicing and the Relevance for Disease – A Focus on Diffuse Gliomas
por: van Asperen, Jessy V., et al.
Publicado: (2022)

Correlations Between the Characteristics of Alternative Splicing Events, Prognosis, and the Immune Microenvironment in Breast Cancer
por: Deng, Youyuan, et al.
Publicado: (2021)

Screening TCGA database for prognostic genes in lower grade glioma microenvironment
por: Ni, Jie, et al.
Publicado: (2020)

Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
por: Franson, Andrea, et al.
Publicado: (2022)

LGG-22. CHARACTERIZATION OF THE TUMOR MICROENVIRONMENT IN PEDIATRIC LOW-GRADE GLIOMA
por: Zahedi, Shadi, et al.
Publicado: (2023)

Altered splicing leads to reduced activation of CPEB3 in high-grade gliomas
por: Skubal, Magdalena, et al.
Publicado: (2016)

Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer
por: Liu, Xuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ftd28bqui75c22fftu29eo3qcn